ROIS, a Global CDMO with its routes in Spain, announced on April 1st, the acquisition of a commercial injectable manufacturing and packaging facility in Phoenix, Arizona (USA). The move marks a key step in ROIS’s evolution into a global Contract Development and Manufacturing Organisation (CDMO), adding US-based sterile fill-finish capability while building on its strong European base. The Phoenix site strengthens ROIS’s ability to develop and manufacture injectable medicines at commercial scale, enhancing capacity, flexibility and speed as well as adding new capabilities for ADC’s and Cytotoxic LYO fill-finish.
Read the full article: ROIS Establishes Itself as Global CDMO with US Expansion //
Source: https://www.prnewswire.com/news-releases/rois-establishes-itself-as-global-cdmo-with-us-expansion-302759256.html